Your cart is empty, and it looks like you haven’t added anything yet.
Pack size: Strip of 10 Tablets | Price is for the whole Strip
⚠ Prescription required. This medicine may only be dispensed against a valid prescription.
Generic: Baricitinib
Form: Tablet 2mg
Rheumatoid Arthritis
Rheumatoid Arthritis Indicated for adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) antagonist therapies May be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs) 2 mg PO qDay
Janus kinases (JAKs) pathways inhibitor; JAK consists of a group of intracellular tyrosine kinases that transmit signals from cytokine or growth factor-receptor interactions on the cellular membrane to influence cellular processes of hematopoieses and immune cell function Within the signaling pathway, JAKs phosphorylate and activate signal transducers and activators of transcription (STATs), which modulate intracellular activity including gene expression; baricitinib modulates the signaling pathway at the point of JAKs, preventing the phosphorylation and activation of STATs
$4b
>10% Upper respiratory tract infections (16.3%) 1-10% Nausea (2.7%) Increased LFTs (1-2%) Platelet elevations (1-2%) Herpes zoster infection (1%) <1% Acne (<1%) Herpes simplex infection (0.8%) Neutropenia (0.3%)
Pregnancy Data in pregnant women are insufficient to inform a drug-associated risk for major birth defects or miscarriage Animal studies In animal embryo-fetal development studies, oral baricitinib administration to pregnant rats and rabbits at exposures equal to and greater than ~20 and 84 times the maximum recommended human dose (MRHD), respectively, resulted in reduced fetal body weights, increased embryo lethality (rabbits only), and dose-related increases in skeletal malformations Lactation Unknown if distributed in human breast milk Baricitinib is present in the milk of lactating rats Owing to species-specific differences in lactation physiology, the clinical relevance of these data are not clear Because of the potential for serious adverse reactions in nursing infants, advise women not to breastfeed while taking baricitinib
$4c
{'list': ['Rheumatoid arthritis']}
{'tag': 'Common', 'list': ['Nausea', 'Upper respiratory tract infection']}
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. __NAME__ may be taken with or without food, but it is better to take it at a fixed time.
__NAME__ is Janus kinase inhibitor. It works by blocking the action of the enzyme, Janus kinase. This decreases inflammation and joint damage in rheumatoid arthritis.
Consuming alcohol with __NAME__ does not cause any harmful side effects.
__NAME__ is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
__NAME__ is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
__NAME__ does not usually affect your ability to drive.
__NAME__ is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.
__NAME__ is safe to use in patients with liver disease. No dose adjustment of __NAME__ is recommended. __NAME__ may not be recommended in patients with severe liver disease due to lack of information and research. Therefore, it is important to consult the doctor.
No review given yet!
Fast delivery across our Dhaka service areas
Safe Payment
7 Days Return Policy
Sourced from licensed pharmacies
You need to Sign in to view this feature
This address will be removed from this list